ITOS: iTeos Therapeutics O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
iTeos Therapeutics kompaniyasining terapevtik oqsil ishlab chiqarishi sinovlar jadvalini qo'llab-quvvatlovchi shartnomaviy ishlab chiqarish tashkilotlari tarmog'iga tayanadi. Kompaniya immunitetga qarshi o'simta himoyasini bloklashga yo'naltirilgan innovatsiyalar bilan ta'minlangan B2B ishlanmalarining yopiq patent perimetri bilan qo'llab-quvvatlanadi. P/E va o'sish sur'atlarining taqqoslovi aktivning bozor dinamikasini namoyish etadi, bunda 0.00 darajasi ushbu ko'rsatkichning joriy qiymatini aks ettirib, aksiyalarning adolatli qiymatini aniqlashga yordam beradi.
iTeos Therapeutics (ITOS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati iTeos Therapeutics|ITOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi iteostherapeutics.com|ITOS - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar iTeos|ITOS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi iTeos Therapeutics|Oraliq likvidlik koeffitsiyenti iteostherapeutics.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ITOS - Sof foyda|Kutilayotgan sof foyda iTeos Therapeutics|ITOS - Narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati iTeos Pharma|ITOS - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati iTeos|ITOS - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda iTeos Therapeutics|ITOS - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati iteostherapeutics.com|ITOS - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi iTeos Therapeutics
Kompaniyaning umumiy tahlili:ITOS - iTeos Therapeutics Inc
iTeos Therapeutics (ITOS) uchun, uning erta immun-onkologiya ishlanmalari sog'liqni saqlash gigantining strategik kapitali bilan qo'llab-quvvatlanmoqda, kelajakdagi o'sishning baholanishi hal qiluvchi ahamiyatga ega. Ushbu ko'rsatkich biznes kengayishining har bir birligi uchun bozor narxining adolatli ekanligini aniqlash uchun P/E koeffitsiyentini foyda o'sish sur'atlari bilan solishtiradi. Bir birlikdan past bo'lgan tarixiy PEG qiymatlari aktivning fundamental salohiyatiga nisbatan qadrsizlanganligidan dalolat beradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Pharvaris Pharma PHVS|ABCL (abcellera.com) - Narx-foyda va o‘sish multiplikatori|TRML: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PGEN (Precigen) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Pharming Group NV PHAR|Narxning foydaga va o‘sish sur’atiga nisbati Nektar (NKTR)|UPB - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Biopharma Inc ZBIO|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati immunome.com (IMNM)|GOSS: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KALV (KalVista Pharma)|SEPN (Septerna Corp) - Narx-foyda va o‘sish multiplikatori|PVLA: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|SVRA (Savara Inc.) - PEG multiplikatori|RIGL: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANAB|ATXS - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati enGene Bio ENGN|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti RAPT|Aerovate - PEG multiplikatori|ACRS - PEG multiplikatori|Kyverna Therapeutics, Inc. (KYTX) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati TLSA (Tiziana Life Sciences Ltd.)|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Ventyx Biosciences, Inc VTYX|Narx-foyda va o‘sish multiplikatori THTX (Theratechnologies Inc.)|PEG multiplikatori avalotx.com (AVTX)|Eledon Pharmaceuticals, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati AGEN (Agenus, Inc.)|Climb Bio, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati zurabio.com ZURA|ATYR: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Adagene Inc.|Narxning foydaga va o‘sish sur’atiga nisbati ImageneBio|Shattuck Therapeutics (STTK) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori EQ|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati connectbiopharm.com|Immunic - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati ATRA (Atara Biotherapeutics, Inc.)|IFRX - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda X4 Pharmaceuticals Inc.|adicetbio.com (ACET) - Narxning foydaga va o‘sish sur’atiga nisbati|CELU - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati INmune Bio, Inc.|barinthusbio.com - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori KZR|SABS (SAB Biotherapeutics Inc.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori AKTX (Akari Therapeutics plc)|PEG multiplikatori Enlivex Therapeutics Ltd ENLV|QTTB - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti GOVX (geovax.com)|Edesa Biotech (EDSA) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori iBio Inc|CARM (Carisma Therapeutics Inc) - PEG multiplikatori|PEG multiplikatori XTL Bio|Narx-foyda va o‘sish multiplikatori BOLT (Bolt Biotherapeutics)|HCWB (hcwbiologics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori APVO (Aptevo Therapeutics Inc.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati aimimmuno.com (AIM)|ADTX - Narxning foydaga va o‘sish sur’atiga nisbati|GRI Bio Corporation (GRI) - Narx-foyda va o‘sish multiplikatori|XORTX Therapeutics Inc. (XRTX) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori reshapelifesciences.com|Narx-foyda va o‘sish multiplikatori REVB|PEG multiplikatori Indaptus Therapeutics Inc|Narxning foydaga va o‘sish sur’atiga nisbati Scinai (SCNI)|calcimedica.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori AFMD (Affimed N.V.)|Allakos Inc (ALLK) - O‘sish sur’atiga tuzatilgan narx-foyda|HOOKIPA - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati IGM Biosciences, Inc. IGMS|OCEA (Ocean Bio) - Narx-foyda va o‘sish multiplikatori|TCBP: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|THRD (Third Harmonic Bio) - PEG multiplikatori
